netFormulary
 Report : A-Z NHS England items in Formulary 16/12/2019 09:45:44
[Back]
 
Section Status NHS England Name
08.01.05 Formulary MHS England Afatinib  
08.02.03 Formulary MHS England Alemtuzumab 
08.01.05 Formulary MHS England Atezolizumab 
08.01.05 Formulary MHS England Axitinib  
03.04.02 Formulary MHS England Benralizumab Fasenra
08.01.05 Formulary MHS England Bosutinib Bosulif
08.01.05 Formulary MHS England Brigatinib Alunbrig
08.01.05 Formulary MHS England Cabozantinib Cometriq
08.01.05 Formulary MHS England Carfilzomib Kyprolis
08.01.05 Formulary MHS England Ceritinib  
08.01.05 Formulary MHS England Dabrafenib  Tafinlar
05.03.03.02 Formulary MHS England Daclatasvir  
08.01.05 Formulary MHS England Dacomitinib Vizimpro
05.03.03.02 Formulary MHS England Dasabuvir Exviera
08.01.03 Formulary MHS England Daunorubicin/cytarabine Vyxeos
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera
08.01.05 Formulary MHS England Dinutuximab beta Qarziba
05.03.03.02 Formulary MHS England Elbasvir & grazoprevir Zepatier
08.01.05 Formulary MHS England Encorafenib Braftovi
08.02.04 Formulary MHS England Fingolimod 
08.02.04 Formulary MHS England Glatiramer Acetate 
05.03.03.02 Formulary MHS England Glecaprevir & Pibrentasvir Maviret
08.01.05 Formulary MHS England Ibrutinib Imbruvica
08.01.05 Formulary MHS England Idelalisib  
08.01.05 Formulary MHS England Imatinib  
08.01.05 Formulary MHS England Inotuzumab ozogamicin Besponsa
08.02.04 Formulary MHS England Interferon Beta Rebif
08.02.04 Formulary MHS England Interferon Beta Betaferon
08.02.04 Formulary MHS England Interferon beta Extavia
08.02.04 Formulary MHS England Interferon Beta Avonex
08.01.05 Formulary MHS England Lenvatinib Kisplyx
03.04.02 Formulary MHS England Mepolizumab Nucala
08.02.04 Formulary MHS England Natalizumab 
08.01.05 Formulary MHS England Nilotinib 
08.02.03 Formulary MHS England Ocrelizumab Ocrevus
08.01.05 Formulary MHS England Olaparib 50mg capsules 
03.04.02 Formulary MHS England Omalizumab 
05.03.03.02 Formulary MHS England Ombitasvir & paritaprevir & ritonavir Viekirax
08.03.04.01 Formulary MHS England Palbociclib Ibrance
08.02.04 Formulary MHS England Peginterferon Beta-1a Plegridy
08.01.05 Formulary MHS England Pertuzumab Perjeta
03.04.02 Formulary MHS England Reslizumab Cinquil
05.03.03.02 Formulary MHS England Ribavirin 
08.03.04.01 Formulary MHS England Ribociclib Kisqali
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi
05.03.03.02 Formulary MHS England Sofosbuvir & Ledipasvir  Harvoni
05.03.03.02 Formulary MHS England Sofosbuvir & velpatasvir  Epclusa
05.03.03.02 Formulary MHS England Sofosbuvir, Velpatasvir & Voxilaprevir  Vosevi
08.01.05 Formulary MHS England Sunitinib  
08.02.04 Formulary MHS England Teriflunomide 
08.01.05 Formulary MHS England Trametinib  
North of Tyne, Gateshead and North Cumbria